| Symbol | CMPS |
|---|---|
| Name | COMPASS PATHWAYS PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 33 BROADWICK STREET,3RD FLOOR, LONDON, W1F 0DQ, United Kingdom |
| Telephone | 1-716-676-6461 |
| Fax | — |
| — | |
| Website | https://compasspathways.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001816590 |
| Description | Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Additional info from NASDAQ: |
Riassunto: Compass Pathways annuncerà i risultati finanziari del secondo trimestre e della prima metà del 2026 il 5 agosto 2026
Read moreSamenvatting: Compass Pathways maakt op 5 augustus 2026 de financiële resultaten over het tweede kwartaal en de eerste helft van 2026 bekend
Read moreCompass Pathways gibt am 5. August 2026 die Finanzergebnisse für das zweite Quartal und das erste Halbjahr 2026 bekannt
Read moreResumen: Compass Pathways anunciará los resultados financieros del segundo trimestre y del primer semestre de 2026 el 5 de agosto de 2026
Read moreCompass Pathways publiera le 5 août 2026 ses résultats financiers du deuxième trimestre et du premier semestre 2026
Read moreCompass Pathways - Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
Read moreCompass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
Read moreCompass Pathways - Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy
Read moreCompass Pathways - Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
Read moreCompass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile
Read more